162 related articles for article (PubMed ID: 35321944)
21. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
Yan D; Chen Y
Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study.
Song CK; Guo ZX; Shen XY; Wang YJ; Wang QW; Yu DH; Chen C; Liu XP; Huang JY; Li S; Hu W
Biomed Res Int; 2020; 2020():7206591. PubMed ID: 32149127
[TBL] [Abstract][Full Text] [Related]
23. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
24. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
26. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomogram based on immune scores for breast cancer patients.
Wang J; Li Y; Fu W; Zhang Y; Jiang J; Zhang Y; Qi X
Cancer Med; 2019 Sep; 8(11):5214-5222. PubMed ID: 31342666
[TBL] [Abstract][Full Text] [Related]
30. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
[TBL] [Abstract][Full Text] [Related]
31. Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
Wang L; Wang W; Zeng S; Zheng H; Lu Q
PLoS One; 2020; 15(12):e0244693. PubMed ID: 33378415
[TBL] [Abstract][Full Text] [Related]
32. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
33. A new clinical prognostic nomogram for liver cancer based on immune score.
Shen Q; Hu G; Wu J; Lv L
PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
[TBL] [Abstract][Full Text] [Related]
34. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma.
Duijm M; Oomen-de Hoop E; van Voort van der Zyp N; van de Vaart P; Tekatli H; Hoogeman M; Senan S; Nuyttens J
Radiother Oncol; 2021 Mar; 156():223-230. PubMed ID: 33418006
[TBL] [Abstract][Full Text] [Related]
35. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
36. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
38. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
40. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
